Neuralink, the neurotechnology company co-founded by Tesla ( NASDAQ: TSLA) CEO Elon Musk, has joined a clinical trial aimed at restoring vision with full or partial blindness through visual prostheses ...

IO Biotech’s off-the-shelf cancer vaccine shows promise in melanoma with key data ahead, but funding risk limits near-term ...

See here for a 3-bucket portfolio offering 5-6% income, market-beating growth, and reduced volatility—ideal for retirees ...

Jyong Biotech targets urinary disorders with a novel botanical pipeline, but clinical and liquidity risks temper near-term ...

Bloom Energy surged on AI hype and an Oracle deal, but valuation looks stretched and risks are rising ahead of earnings. Read ...

By Elle Caruso Fitzgerald Corporate dividends and MLP distributions are two forms of company payouts for investors seeking income.

Lithium Argentina sees strong Q1 2025 margins, scalable growth to 200K+ tons with DLE tech, and untapped upside from ...

Sarepta Therapeutics (SRPT) in focus as the biotech says the death of a patient who had received its gene therapy Elevidys ...

Patience pays in energy investments. See why I'm doubling down on energy despite market impatience, fading reserves, and slow ...

Workday is a compelling Buy opportunity with strong margins, AI potential, and 20-30% upside despite growth concerns. Read ...

Dow faces significant headwinds, tariffs, and weak global demand. Is it a good time to buy the dip after the dividend cut and ...

Alphabet is growing fast in core and cloud segments, though rising AI capex is pressuring free cash flow and returns. Learn ...